CSIMarket


Eli Lilly And Company  (LLY)
Other Ticker:  
 

Eli Lilly And Company

LLY's Fundamental analysis






Looking into Eli Lilly growth rates, revenue grew by 16.14 % in I. Quarter 2021 from the same quarter a year ago. Ranking at No. 261

Major Pharmaceutical Preparations industry recorded growth of revenues by 13.31 %

Eli Lilly's net profit deacreased by -6.95 % in I. Quarter 2021 year on year, to $1,355 millions.

More on LLY's Growth


Eli Lilly
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Eli Lilly PEG ratio is at 2.81 Company is currently trading with Price to Cash flow multiple of 136.8 in trailing twelve-month period.
Company
29.25
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.13.

Eli Lilly Price to Book Ratio is at 25.12 lower than Indusry Avg. of 1629.32. and higher than S&P 500 Avg. of -0.02

More on LLY's Valuation
 
 Total Debt (Millions $) 16,205
 Dividend TTM ($) 3.06 $
 Dividend Yield TTM (%) 1.74 %
 Revenue/Employee (TTM) $ 757,936
 Net Income/Employee (TTM) $ 181,190
 Receivable Turnover (TTM) 4.81
 Tangible Book Value (Per Share $) -5.33

Eli Lilly
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Eli Lilly PEG ratio is at 2.81 Company is currently trading with Price to Cash flow multiple of 136.8 in trailing twelve-month period.
Company
29.25
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.13.

Eli Lilly Price to Book Ratio is at 25.12 lower than Indusry Avg. of 1629.32. and higher than S&P 500 Avg. of -0.02

More on LLY's Valuation

  Market Capitalization (Millions $) 178,301
  Shares Outstanding (Millions) 912
  Employees 33,625
  Revenues (TTM) (Millions $) 25,486
  Net Income (TTM) (Millions $) 6,093
  Cash Flow (TTM) (Millions $) 1,303
  Capital Exp. (TTM) (Millions $) -1,430
  Total Debt (Millions $) 16,205
  Dividend TTM ($) 3.06 $
  Dividend Yield TTM (%) 1.74 %
  Revenue/Employee (TTM) $ 757,936
  Net Income/Employee(TTM) $ 181,190
  Receivable Turnover Ratio (TTM) 4.81
  Tangible Book Value (Per Share $) -5.33

  Market Capitalization (Millions $) 178,301
  Shares Outstanding (Millions) 912
  Employees 33,625
  Revenues (TTM) (Millions $) 25,486
  Net Income (TTM) (Millions $) 6,093
  Cash Flow (TTM) (Millions $) 1,303
  Capital Exp. (TTM) (Millions $) -1,430

LLY's Profitability Comparisons
Eli Lilly faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2021 to 16.98 % from 26.78 % in IV. Quarter.

Eli Lilly net profit margin of 19.91 % is currently ranking no. 19 in Major Pharmaceutical Preparations industry, ranking no. 41 in Healthcare sector and number 603 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 2.82
  Total Debt to Equity (MRQ) 2.28
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.57
  Inventory Turnover Ratio (TTM) 1.69



Eli Lilly faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2021 to 16.98 % from 26.78 % in IV. Quarter.

Eli Lilly net profit margin of 19.91 % is currently ranking no. 19 in Major Pharmaceutical Preparations industry, ranking no. 41 in Healthcare sector and number 603 in S&P 500.

More on LLY's Key Ratios





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PASG's Profile

Stock Price

PASG's Financials

Business Description

Fundamentals

Charts & Quotes

PASG's News

Suppliers

PASG's Competitors

Customers & Markets

Economic Indicators

PASG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071